SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 17, 2020

 

 

AMERICAN CANNABIS COMPANY, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

(State or other jurisdiction of incorporation or organization)

Commission File Number

000-26108

90-1116625

(I.R.S. Employer

Identification Number)

 

5690 Logan St # A, Denver, Colorado 80216

(Address of Principal Executive Offices and Zip Code) 

(303) 974-4770

(Issuer's telephone number)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 
 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

(a) On April 17, 2020 the Registrant adopted an amendment to its certificate of incorporation increasing the number of its authorized shares from one hundred million to five hundred million common shares, par value $0.00001 per share. No amendment was adopted concerning the Registrant’s preferred shares.

Section 9 – Financial Statement and Exhibits

Item 9.01 Financial Statements and Exhibits

Exhibit No. Document Location

3(i) Text of Amendment Filed Herewith

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated April 20, 2020

 

AMERICAN CANNABIS COMPANY, INC.

(Registrant)

 

By: /s/ Terry Buffalo

Terry Buffalo

Principal Executive Officer

 

Exhibit 3(i)

 

Article Fourth: The Corporation shall be authorized to issue two classes of stock outstanding, consisting of five hundred million (500,000,000) shares of Common Stock, par value $0.00001 per share, and five million (5,000,000) shares of Preferred Stock, par value $0.01 per share.

The number of authorized shares of stock of any class may be increased or decreased (but not below the number of shares thereof then outstanding) by an affirmative vote of the holders of a majority of the stock of the corporation entitled to vote pursuant to the provisions of the Delaware General Corporation Law and the Corporation’s By Laws. The Preferred Shares shall be issued from time to time in on or more series, with such distinctive serial designations and rights as shall be stated and expressed in the resolution or resolutions providing for the issue of such shares as adopted by the Board of Directors in its sole discretion; the Board of Directors are authorized to fix the annual rate or rates of dividends for the particular series, the dividend payment dates for the particular series, and the date from which dividends on all shares of such series issued prior to the effective date for the first dividend payment shall be cumulative, the redemption price or prices for the particular series, the voting powers of the particular series, the rights, if any, of holders of the particular series to convert the same into shares of any other series or class or other securities of the Corporation, with any provisions for subsequent adjustment of such conversion rights, the rights, if any, of the particular series to participate in distributions or payments upon liquidation, dissolution, or winding up of the Corporation, and to classify or reclassify any unissued preferred shares by fixing or altering from time to time, any of the foregoing rights, privileges or qualifications.

All of the preferred shares of any one series shall be identical with each other in all respects, except that the shares of any one series issued at different times may differ as to the dates from which dividends thereon shall be cumulative; and all preferred shares shall be of equal rank, regardless of series, and shall be identical in all respects except as to the particulars fixed by the Board of Directors in its sole discretion as hereinabove provided or as fixed herein.